Published in Dig Surg on July 02, 2009
The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study. BMC Surg (2011) 0.96
Risk factors for excess mortality in the first year after curative surgery for colorectal cancer. Ann Surg Oncol (2012) 0.92
Prognostic significance of peritoneal lavage cytology in patients with colorectal cancer. Int J Clin Oncol (2012) 0.80
Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection. Ann Surg Treat Res (2014) 0.79
Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival? Int J Colorectal Dis (2013) 0.78
Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer. World J Gastroenterol (2010) 0.77
An FDG-PET/CT-positive lesion mimicking local recurrence of colon cancer 5 years after radical colectomy. Am J Case Rep (2015) 0.75
Role of pulmonary metastasectomy in colorectal cancer in the era of modern multidisciplinary therapy. Surg Today (2017) 0.75
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39
A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg (2007) 3.92
A two-step method for marking polypectomy sites in the colon and rectum. Gastrointest Endosc (2003) 3.63
Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries. Int J Cardiol (2008) 2.78
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). Lancet Oncol (2010) 2.73
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70
Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology (2004) 2.66
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol (2013) 2.45
Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol (2009) 2.43
Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol (2009) 2.34
Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol (2012) 2.32
Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res (2004) 2.24
Clinical significance of the mesorectal extension of rectal cancer: a Japanese multi-institutional study. Ann Surg (2011) 2.23
Long-term comparison of laparoscopy-assisted distal gastrectomy and open distal gastrectomy in advanced gastric cancer. Surg Endosc (2012) 2.23
New criteria for histologic grading of colorectal cancer. Am J Surg Pathol (2012) 2.20
The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma. Pancreas (2004) 2.05
Percutaneous transesophageal gastrostomy tube for decompression of malignant obstruction: report of the first case and our series in the US. J Am Coll Surg (2005) 2.02
Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery (2006) 1.96
Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut (2007) 1.87
PIK3CA mutation is predictive of poor survival in patients with colorectal cancer. Int J Cancer (2007) 1.79
Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum (2006) 1.74
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res (2008) 1.73
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol (2008) 1.68
Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. J Card Fail (2007) 1.66
A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg (2014) 1.65
Gut ischemia-reperfusion affects gut mucosal immunity: a possible mechanism for infectious complications after severe surgical insults. Crit Care Med (2006) 1.63
Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg (2007) 1.60
Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum (2003) 1.60
Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Ann Surg Oncol (2008) 1.59
Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res (2002) 1.58
Role of Toll-like receptors in the development of sepsis. Shock (2008) 1.57
DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int J Cancer (2009) 1.56
Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma. Dis Colon Rectum (2006) 1.54
Sema3A regulates bone-mass accrual through sensory innervations. Nature (2013) 1.53
Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients. Dis Colon Rectum (2011) 1.51
Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum (2003) 1.51
Epithelial cyst of the gallbladder associated with adenocarcinoma. J Hepatobiliary Pancreat Surg (2002) 1.49
Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer. Ann Thorac Surg (2007) 1.45
Disappearance of HCV after cessation of immunosuppression in a patient with ulcerative colitis and renal transplantation. J Gastroenterol (2005) 1.44
Risk factors of nodal involvement in T2 colorectal cancer. Dis Colon Rectum (2010) 1.44
Nonparasitic solitary huge liver cysts causing intracystic hemorrhage or obstructive jaundice. J Hepatobiliary Pancreat Surg (2002) 1.44
Intraoperative intercostal nerve blockade for postthoracotomy pain. Ann Thorac Surg (2002) 1.43
Usefulness of endoscopic breast-conserving surgery for breast cancer. Surg Today (2013) 1.42
The relationship of lymph node evaluation and colorectal cancer survival after curative resection: a multi-institutional study. Ann Surg Oncol (2012) 1.42
Contrast-enhanced ultrasound imaging of carotid plaque neovascularization is useful for identifying high-risk patients with coronary artery disease. Circ J (2013) 1.40
Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol (2008) 1.40
Evaluation of the Japanese Gastric Cancer Association's Gastric cancer treatment guidelines for popular use. Gastric Cancer (2004) 1.39
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol (2010) 1.39
Current status in the occurrence of postoperative bleeding, perforation and residual/local recurrence during colonoscopic treatment in Japan. Dig Endosc (2010) 1.38
Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. Clin Cancer Res (2003) 1.38
High expression of HER3 is associated with a decreased survival in gastric cancer. Clin Cancer Res (2008) 1.38
Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol (2004) 1.35
Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin Cancer Res (2012) 1.34
Intersphincteric resection in patients with very low rectal cancer: a review of the Japanese experience. Dis Colon Rectum (2006) 1.34
Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404. Ann Surg (2014) 1.32
Reactive lymphoid hyperplasia of the liver: a case report and review of literature. World J Gastroenterol (2007) 1.31
Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg (2012) 1.31
Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci (2007) 1.28
Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications. Surgery (2012) 1.26
A new prognostic staging system for rectal cancer. Ann Surg (2004) 1.26
Successful gastric submucosal tumor resection using laparoscopic and endoscopic cooperative surgery. World J Surg (2012) 1.25
Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum (2003) 1.25
A comparison of Roux-en-Y and Billroth-I reconstruction after laparoscopy-assisted distal gastrectomy. Ann Surg (2008) 1.24
Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg (2006) 1.24
Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol (2007) 1.24